Studies have shown that the mRNA and protein expression levels of the immune checkpoint molecules PD-L1 and CTLA4 are also closely related to high TILs, an active immune response, and a “hot” immune microenvironment, which is beneficial for the tumor-targeted immune response or immunotherapy (17, 18). The gene discussed is CD274; the disease is neoplasm.